In our research, it was demonstrated for the first time that PLGA-encapsulated formononetin upregulates PRDM16, which activates the NRF2/GPX4 pathway, thereby inhibiting ferroptosis and reducing sepsis-induced multi-organ injury, including AKI. The gene discussed is GPX4; the disease is acute kidney injury.